A Collection of Position Statements and Opinions on e-cigarette use and cardiovascular disease: On behalf of the Working Group on Epidemiology of the Hellenic Atherosclerosis Society

J Atherosclerosis Prev Treat. 2022 Sep-Dec;13(3):119–125 | doi:10.53590/japt.02.1041


Venetia Notara1, Vassiliki Bobolou1, Alexandra Foscolou2, Matina Kouvari3,4, Eleni Chelioti5, Emmanuella Magriplis6, Demosthenes Panagiotakos3,4

1Department of Public and Community Health, Laboratory of Hygiene and Epidemiology, School of Public Health, University of West Attica, Athens, Greece
2Department of Nutrition & Dietetics, School of Physical Education, Sports and Dietetics, University of Thessaly, Trikala, Greece
3Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece
4Faculty of Health, University of Canberra, ACT, Australia
5Department of Nephrology, General Hospital of Piraeus, Tzaneio Greece
6Laboratory of Dietetics and Quality of Life, Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Greece



There are accumulative evidences that the prevalence of cigarette smoking has gradually declined in most high-income countries since the 1990s, in part due to public health campaigns emphasizing on the relationship between tobacco use and detrimental health effects. In late 2000s electronic (e)-cigarettes were introduced in the world, as less harmful nicotine products that may also help people in quitting smoking. Since then, the use of e-cigarettes has increased rapidly from the time when their introduction in the global market. In this work we present a collection of position statements and opinions of scientific bodies and Organizations, regarding the safety of e-cigarettes, as well as their association with human health, and particularly, cardiovascular diseases.

Key Words: Position statements, e-cigarettes, vaping, cardiovascular disease.

Corresponding author: Venetia Notara, Assοciate Professor, School of Public Health, Department of Public and Community Health, University of West Attica, Athens, Greece, Tel.: +30 213 2010127, E-mail: vnotara@uniwa.gr

Submission: 09.09.2022, Acceptance: 24.09.2022


It is well constituted that conventional cigarette smoking increases risk for cardiovascular disease, in current smokers and passive smokers1, even among those smoking cigarettes of low tar2, compared to non-smokers. Evidence took decades to accumulate since associated health risks to cigarette smoking are both dose and duration dependent3.  Since this evidence came to light, tobacco related products emerged, one of which is the electronic cigarette/nicotine delivery systems, as safer tobacco products, driven from the tobacco companies themselves, although recent studies suggest increased health risks, at a level that may surpass the traditional cigarette smoking itself3.

In 2003, electronic (e)-cigarettes were patented by Hon Lik, in China. In the year that followed, they became available for purchase, firstly in China, and then, in the entire world6. In the United States of America, they have been available since 2007 and one year prior to that, in the European Union (E.U.)8. There are several synonyms of electronic (e)-cigarettes, i.e., Electronic Nicotine Delivery Systems (ENDS), “e-cigs”, “vape-pens”, “mods”, “e-cigars”, according to the Centers of Disease Control and Prevention (CDC)4. The American Heart Association (AHA) defines electronic cigarettes (e-cigarettes) and vaping, respectively, as “battery-powered devices that can deliver nicotine and flavorings to the user in the form of an aerosol”, and “the act of inhaling and exhaling the aerosol, often referred as vapor, which is produced by an e-cigarette or similar device5.

From the time e-cigarettes became available in the market, and up to date, there are controversial findings regarding their effects on health. The principle, promoting idea was that e-cigarettes constituted a healthier option compared to traditional cigarettes, and assist in quitting cigarette smoking6. According to the European Heart Network (EHN), “e-cigarettes are promoted as risk-reducing products compared to combustible tobacco cigarettes7, while the European Association of Preventive Cardiology (EAPC) states that they “are promoted as safe alternatives for traditional tobacco smoking and are often suggested as a method to reduce or quit smoking8. In addition, it is stated by the World Health Organization (WHO), that with the pretense of helping public health, ENDS companies, advertise, and promote ENDS and make flavors to attract youths to increase the number of their customers9. This is an area of concern since ENDS-related harm perception did not increase among adolescents 12- to 17-year-old that did not have positive tobacco attitude and lived in smoke free home rules10. Furthermore, smoke free environments have been established in many countries for tobacco related products for public health prevention, but few for ENDS, which may also expose individuals to nicotine and particulate matters11; substances that can trigger inflammation, oxidative stress, and other thrombotic effects3. A population survey of ENDS users reported that 58% of dual users (ENDS and cigarettes) used ENDS in public smoke free environments12, intensifying the need to review position statements and opinions by experts in the field.


World Health Organization (WHO)

The past two decades data from the WHO indicated that global tobacco use has been significantly reduced, especially among women6; however, e-cigarettes is an emerging trend, especially among younger individuals. These are not harm free since it is stated that toxic materials and nicotine are present in ENDS at varying quantities6. Specifically, long-term effects to nicotine exposure have been associated with abnormal brain development, seen in fetuses, children, teenagers, and youths6. Chemical addiction can, therefore, occur through e-smoking as well, which in turn can result in the use of traditional tobacco products, instead of the preliminary reason they were marketed, which was tobacco smoke cessation. It has been estimated that the possibility of smoking increases two-fold for underage individuals who e-smoke, although they had never smoked6. Public health officials’ positions report that e-cigarettes can constitute “a “gateway” to conventional smoking among young people6.

The health of e-smokers is not the only one harmed by ENDS. As stated previously, ENDS emit nicotine and particulate matters, therefore expose individuals, that are near a person who is e-smoking, to second hand aerosols6, in an otherwise “smoke-free” environment. In addition, children may be exposed, or even drink e-liquid, and suffer from poisoning. Moreover, ENDS may be altered by their owners or may be faulted from the manufacturer leading to accidents, such as explosions or fires6.

Based on a recent scoping review, the toxicity of traditional cigarettes is probably higher compared to ENDS, since it was not revealed ENDS to be causative of CVD outcomes as well as that switching to e-cigarettes was associated with improved hypertension control13.  However, the long-term effects of ENDS remain unknown, due to the inadequacy of evidence, and controversial findings remain due to the variety of ENDS products (device voltage, liquid composition, the amount of vapor inhaled, etc.). It is also important to note that most e-cigarette users are former smokers or dual users, increasing the difficulty to differentiate the effects. Various factors most likely will determine how risky tobacco products or ENDS are and can vary between person and by ENDS product. Specifically, for cardiovascular disease, it is supported that an increased risk can occur from e-smoking, due to various constituents, such as nicotine, carbonyls, and particulate matters, although a recent scoping review found no such effect14. How health will be affected in the long term hasn’t yet been determined for all people who breathe aerosols. Also, it hasn’t been determined by evidence, so far, that ENDS can serve in smoking cessation, as aids, since most of the e-cigarette users are dual users15. Negative consequences have also been added to the previous fact, since it has been shown that never smokers are more likely to start ENDS products by younger individuals, viewed as safe products13.

Tobacco control measures can be weakened by ENDS, and there is a possibility that the certain devices might “escape” laws, because they change in a quick pace. Regulation of ENDS is suggested for countries where they are allowed6, and although 48 countries (58.3%) have legislation on e-cigarette use at the national level, only a third regulated e-cigarette indoors, failing to protect bystanders in indoor settings16.

World Heart Federation (WHF)

The WHF perceives un-regulated e-cigarette use a serious threat and recommends a set of precautionary measures to protect vulnerable population, prevent second-hand exposure and address misleading claims9. The following presents some statements from a Policy Brief by the WHF (2021), regarding cardiovascular health and e-cigarettes. It is noted by the WHF that an association exists between increased risk of cardiovascular mortality and morbidity, and vaping. Atherosclerosis, elevation of blood pressure, increased risk of myocardial infarction and oxidative stress are parts of several health problems that have been associated with vaping. Evidence supports that e-cigarettes may lead to similar cardiovascular problems as cigarettes, because they both share the same health-harming substances; yet, the risk is lower in e-cigarette smokers, at least in former smokers. According to the evidence, the short-term cardiovascular health benefits of e-cigarettes seem to be positive. In cases where vaping is used alongside with cigarette, then there is a possibility that the CVD risk rises. The WHF also noted that it is very difficult to determine the exact health effects of vaping, due to the various ways of use, devices, populations, flavors, and e-liquids. Moreover, regarding Public Health and e-cigarettes, it is stated that other diseases must be considered in the evaluation of the consequences.

Another crucial issue, according to the WHF, is the fact that popularity of e-cigarettes/vaping has risen tremendously in the past years, among younger ages. The design, the different flavors and because the new fashion trend are the main reason for increased use in youths. Misleading advertising on the safety of e-smoking and extended marketing remain serious incentives for smoking initiation on that vulnerable age group. It is therefore suggested -among others- that an additional taxation on e-cigarettes, a ban on marketing, sale and distribution can effectively reduce e-cigarettes among those ages. In addition, vaping and smoking should share the same ban regarding the places where is it not allowed, and restrictions regarding commercialization of e-cigarettes shouldn’t be lifted by countries who are applying them.

Irrespective of age, all individuals should be safeguarded and preventative strategies against e-smoking/vaping should be implemented. Tobacco control legislation must be reinforced by future laws regarding e-cigarettes, and more scientific evidence is needed regarding the long-term effects of e-smoking/vaping on cardiovascular health. Lastly, further studies must take place on the topic of long-term effects of e-cigarettes on cardiovascular health9.

European Commission: Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)

The SCHEER was mandated (2019) by the European Commission for an opinion on the potential risks of e-cigarettes use on health. The Committee concluded that, in relation to vaping, risks of long-term systemic effects on cardiovascular system are supported moderately by evidence. Moreover, it is weakly supported that aerosol metals can cause adverse effects, particularly carcinogenicity. Evidence in characterized as weak to moderate, regarding “risks of carcinogenicity of the respiratory tract due to long-term cumulative exposure to nitrosamines and due to exposure to formaldehyde and acetaldehyde”.  In addition, it is not supported by specific data that certain flavors in the European Union are risky for health after repeated exposure. Risks of other adverse health effects, like reprotoxic effects and pulmonary disease, are weakly supported and there is a need for additional data that presents consistency. Also, it is moderately supported that cumulative exposure to aldehydes, polyols and nicotine causes risks of local irritative damage to the respiratory tract. Additionally, risks of poisoning and injuries due to burns and explosion are strongly supported by evidence. The incidence of the last two health problems is described as low.

Equivalently, for people who are exposed to vaping second-hand, evidence is described as weak to moderate regarding “carcinogenic risk due to cumulative exposure to nitrosamines”. Additionally, it is moderately supported by evidence “risks of local irritative damage to the respiratory tract mainly due to exposure to glycols”. Specifically, about cardiovascular health, evidence is characterized as weak to moderate, regarding risks of systemic cardiovascular effects due to nicotine exposure.

Possible health effects on people who vape occur mostly due to the vapor’s substances. The particular substances, including nicotine, differ in their quantities. Specifically, for nicotine, it is strongly supported that the pattern of which e-cigarettes are vaped by their owner and the specifications of the e-cigarettes, determine the quantity of the chemical that is being consumed. Moreover, the quantity can be put side by side with traditional cigarettes, regarding long term e-smoking adults.

It is strongly supported that one of the reasons of vaping is appealing to people due to e-liquid flavors. Moreover, evidence is characterized as strong, regarding the involvement of nicotine in people becoming addicted. It is moderately supported that vaping is a “gateway to smoking” for young individuals and weakly supported that e-cigarettes are effective for smoking cessation. Evidence is characterized as weak to moderate, regarding e-cigarettes assisting people to decrease smoking. People haven’t been exposed to vaping for many years and health effects, especially those of the long term, need to be studied further17.

US Centers Disease Control (CDC)

The US CDC states that more harm is caused by traditional smoking compared to vaping, and however, vaping is quoted as not entirely safe for young ages4. E-cigarettes seem to be risky during pregnancy and for young adults and adults who do not use tobacco products. Children have been poisoned by swallowing, inhaling or ingesting e-cigarette liquid through the skin or eyes. Specifically, almost half of the calls to poison control centers for e-cigarettes, concern preschooler children. As referenced by the CDC, the Food and Drug Administration (FDA) does not recommend e-cigarettes for smoking cessation, and the U.S. Preventative Services Task Force reports evidence as inadequate to support the use of e-cigarettes as a stop smoking aid, regarding adults and pregnant women. However, it seems they may provide a kind of smoking cessation support only if they are not used dually with cigarette smoking. Yet, evidence reveals that most e-smokers are also cigarette smokers. It is obvious that more research is needed regarding the long-term health effects of e-smoking as well as the benefit in smoking cessation4.

European Heart Network (EHN), European Association of Preventive Cardiology (EAPC)


The recent report of the EHN addressed two main issues about the effects of e-cigarettes/vaping on cardiovascular health and their effectiveness on smoking cessation. Even though, the short-term effects on cardiovascular health are not quite clear and the evidence seems to be inconclusive, however it is supported that the risk still exists. Compared to conventional smoking, e-smoking is less harmful due to the absence of several toxic and carcinogenic agents, but it does not mean that it is safe and without health complications. For the long-term effects, more robust evidence is needed. However, there is good evidence supporting that heart rate may increase shortly after nicotine intake from vaping and may affect platelet functionality, blood pressure, and oxidative stress7. Moreover, up to date there is no sufficient evidence that e-cigarettes constitute an effective mean regarding smoking cessation. Additionally, a large majority of those who use e-cigarettes, as a smoking cessation process, they end up as dual smokers with increased health risks. The increased rate of e-smoking/vaping among young ages, starting from adolescence is quite alarming. A factor that has led to this increase is the appealing flavors provided for e-cigarettes and since the perception of safe to consume in contrast to traditional smoking. There is a possibility that public health will be affected in a negative way by e-cigarettes. The industry-related conflict of interest influence on results of studies to support the safety of e-cigarettes, regarding their health effects, constitutes another problem. Regulations on e-cigarette taxation, on restricting e-smoking in public places and on banning marketing and flavors could eliminate the use of e-cigarettes mainly among young ages7.


The EAPC of the European Society of Cardiology (ESC) published in 2021 a position statement on e-cigarettes and cardiovascular risk8. The EAPC concluded that, regarding the prevalence of vaping, it differs from country to country, within a country, and between people who currently vape or have vaped. However, the prevalence, among youth and teenage age groups, is rising. Additionally, it is supported that the possibility of smoking traditional cigarettes rises because of the prevalence of vaping in the certain age groups. Regarding CVD, the effects of vaping haven’t been studied extensively. The belief that traditional cigarettes are more damaging than e-cigarettes is because the exposure to potentially toxic chemicals -with the exception of nicotine- is higher in cigarettes, under regular vaping circumstances. Regarding the cardiovascular system, the effects in the long term of vaping are mostly not comprehended. According to research, endothelial dysfunction and arterial stiffness constitute some health problems that can be caused by e-smoking. In addition, due to the rise of e-smoking in vulnerable populations, the “benefit” of lesser damage will not be completely balanced out. EAPC agrees that vaping is harming to the cardiovascular system, according to evidence and additional research on its effects in the long term must take place, with young people being prone, due to their wrongful healthiness perception. Because of this, it is suggested that a ban should be placed on those flavors. Additionally, indoor smoking or vaping, the attainment of e-cigarettes by bypassing laws and the possible reasons why youths might be drawn to them constitute other existing issues. It can be concluded that young peoples’ health can be put in danger, and for vaping to be as limited as possible, public health action must be taken. Regarding the previous, prevention via education and awareness can help. It is stated that regulations haven’t been keeping up with the market of e-cigarettes and therefore laws must be adjusted accordingly and enforced. In addition, it is suggested that laws must be formed, regarding e-cigarettes, by countries that don’t have them. It is also noted that evidence is described as inadequate, regarding e-cigarettes in smoking cessation and assisting in long-term maintenance of not smoking. It is also supported that abstinence percentages might grow if behavioral therapy and vaping are used together in smoking cessation. However, if e-smoking is utilized exclusively in a clinical environment, there is a possibility that cessation will be weakened for most adults that are trying to quit without attending such environments. Further studies must be conducted for longitudinal data to be attained regarding smoking cessation and the impact of e-cigarettes on it8.

Existing recommendations in relation to position statements

A recent Scoping Review, upon collecting 81 statements from international health organizations with regards to the use of ENDS, observed that they could be summarized in a total of 5 different types18. Overall, two encouraged their use by smokers and three were opposed to it. The most prevalent opposing statement was the restrictive non-use attitude.

a) Support Selective Use

Encouragement of current smokers to use ENDS as a smoking cessation assistance. The user should be informed of alternative licensed drugs and counseling alternatives. Regulating ENDS as pharmaceuticals would increase product safety and permit marketing limits. The availability and usage of ENDS cannot interfere with current tobacco control initiatives, such as smoke-free regulations.

b) Selective Use Encouragement

Encouragement of smokers to transition to only using e-cigarette or to use e-cigarette as a quitting aid. Product innovation, user attractiveness, lower taxation, and health messages emphasizing e-cigarette’s lower harm should be prioritized in vaping regulation.

c) Precautionary non-use

Although ENDS are probably less dangerous than cigarettes, it is still unclear whether they expose users to long-term hazards or serve as successful cessation assistance. Until more information is available, use is not advised. To be on the safe side, smokers should be urged to stop using medications that have already received approval. Until new safety precautions are put in place and/or new data is available, these recommendations shouldn’t be changed. It is advised to carry on researching.

d) Restrictive non-use

ENDS should be avoided since they undermine tobacco control efforts. According to the evidence that is currently available, consumption is not advised, and restrictions should concentrate on limiting business operations and product accessibility. ENDS need to be governed like tobacco.

e) Prohibit use

To prevent health concerns, ENDS-containing items should be illegally unavailable.

Unresolved issues and evidence gaps

Even though e-smoking/vaping is not considered entirely safe and several efforts have been made to underline the risks posed by the exposure to first-hand and second-hand e-smoking, still several issues need to be clarified. In Table 1 unresolved issues and evidence gaps which need to be addressed by evidence-based research are presented.

Unresolved issues and evidence gaps

Even though e-smoking/vaping is not considered entirely safe and several efforts have been made to underline the risks posed by the exposure to first-hand and second-hand e-smoking, still several issues need to be clarified. In Table 1 unresolved issues and evidence gaps which need to be addressed by evidence-based research are presented.

Conclusive remarks

Although ENDS started as an initiative to help quit traditional smoking, there is week to moderate evidence to support this strategy, as noted by the European Commission as well. On the contrary, there is research depicting that ENDS cannot be regarded as a complete safe alternative to tobacco and further research needs to take place for the determination of its effects on health in the long term. In addition, many ENDS with vaping being higher in the list, has negative effects on the cardiovascular system and further research needs to be conducted for the determination of its effects in the long term on the said system. Moreover, youths may start smoking because of the appealing taste and wrongful perception of vaping and thus, more regulations to ban e-cigarette use for minors are needed. Also, exposure to harmful particulate is rising again since indoor regulation of ENDS are lacking by two-out-of-three of the countries, worldwide21. Lastly, public health initiatives that discourage non-smokers from using e-cigarettes and/or conventional cigarettes, by intensifying health awareness programs are urgently required.

Conflict of interest

There are no conflicts of interest.


  1. Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: A meta-analysis. Medicine (Baltimore) 2019 Mar;98(12):e14872.
  2. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):11-29.
  3. Alarabi AB, Lozano PA, Khasawneh FT, Alshbool FZ. The effect of emerging tobacco related products and their toxic constituents on thrombosis. Life Sci. 2022 Feb;290:120255.
  4. Centers of disease control and prevention (CDC). [Internet] Atlanta: The Centers; c2022. About Electronic Cigarettes (E-Cigarettes); 2022 Mar 21[cited 2022 Jul 21];[about 10 screens]. Available from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html
  5. Wold LE, Tarran R, Crotty Alexander LE, Hamburg NM, Kheradmand F, et al, American Heart Association Council on Basic Cardiovascular Sciences; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; and Stroke Council. Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement from the American Heart Association. Circ Res. 2022 Jul;131(3):e70-e82.
  6. World Health Organization (WHO). WHO Report on the Global Tobacco Epidemic, 2019. [PDF] Geneva: The Organization; 2019 [cited 2022 Jul 29] p. 56-59. Available from: https://apps.who.int/iris/handle/10665/326043 by downloading the file.
  7. European Heart Network (EHN). Electronic cigarettes and cardiovascular disease – an update from the European Heart Network [Internet]. Brussels: The Network; 2019 [cited 2022 Jul 20] Available from: https://ehnheart.org/images/EHN_e-cigarettes_final_final.pdf
  8. Kavousi M, Pisinger C, Barthelemy JC, Smedt D, Koskinas K, Marques-Vidal P, et al. Electronic cigarettes and health with special focus on cardiovascular effects: Position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol [Internet]. 2020 :2047487320941993. Online ahead of print. Available from: https://pubmed.ncbi.nlm.nih.gov/32726563/
  9. World Heart Federation (WHF). E-cigarettes: A New Threat to Cardiovascular Health – A World Heart Federation Policy Brief. [Internet] Geneva: The Federation; 2021; [cited 2022 Aug 1]. Available from: https://world-heart-federation.org/wp-content/uploads/E-cigarettes-Policy-Brief.pdf
  10. Li W, Osibogun O, Li T, Sutherland MT, Maziak W. Changes in harm perception of ENDS and their predictors among US adolescents: findings from the population assessment of tobacco and health (PATH) study, 2013-2018. Prev Med. 2022 Feb;155:106957.
  11. Goniewicz ML, Lee L. Electronic cigarettes are a source of thirdhand exposure to nicotine. Nicotine Tob Res. 2015 Feb;17(2): 256-8.
  12. Dunbar ZR, Giovino G, Wei B, O’Connor RJ, Goniewicz ML, Travers MJ. Use of electronic cigarettes in smoke-free spaces by smokers: Results from the 2014-2015 Population assessment on tobacco and health study. Int J Environ Res Public Health. 2020 Feb;17(3):978.
  13. Münzel T, Hahad O, Kuntic M, Keaney JF, Deanfield JE, Daiber A. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J 2020 Nov;41(41):4057-70.
  14. Hajat C, Stein E, Shantikumar S, Niaura R, Ferrara P, Polosa R. A scoping review of studies on the health impact of electronic nicotine delivery systems. Intern Emerg Med. 2022 Jan;17(1):241-68.
  15. Khadka S, Awasthi M, Lamichhane RR, Ojha C, Mamudu HM, Lavie CJ, et al. The cardiovascular effects of electronic cigarettes. Curr Cardiol Rep. 2021 Mar;23(5):40.
  16. Amalia B, Fu M, Feliu A, Tigova O, Fayokun R, Mauer-Stender K, et al. Regulation of electronic cigarette use in public and private areas in 48 countries within the who european region: A survey to in-country informants. J Epidemiol. 2022;32(3):131-38.
  17. European Commission (E.U.). Scientific Committee on Health, Environmental and Emerging Risks SCHEER: Opinion on electronic cigarettes. [Internet] Brussels: The Commission; 2021 Apr 16 [cited 2022 Jul 20] p 2, 10-19. Available from: https://health.ec.europa.eu/system/files/2022-08/scheer_o_017.pdf
  18. Brady BR, De La Rosa JS, Nair US, Leischow SJ. Electronic cigarette policy recommendations: A Scoping Review. Am J Health Behav 2019 Jan;43(1):88-104.
  19. US Food and Drug Administration (FDA). E-Cigarettes, Vapes, and other Electronic Nicotine Delivery Systems (ENDS);2019 [cited 2022 Aug 30]. Available from: https://www.fda.gov/tobacco-products/products-ingredients-components/e-cigarettes-vapes-and-other-electronic-nicotine-delivery-systems-ends.
  20. World Health Organization (WHO). Tobacco: E-cigarettes; 2022 [cited 2022 Aug 30]. Available from: https://www.who.int/news-room/questions-and-answers/item/tobacco-e-cigarettes.
  21. World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2025, 3rd ed. Geneva; 2019. Available from: https://www.who.int/publicationsdetail/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition (31 May 2020).